Danica Pension Livsforsikringsaktieselskab Makes New Investment in Avantor, Inc. $AVTR

Danica Pension Livsforsikringsaktieselskab acquired a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 63,072 shares of the company’s stock, valued at approximately $624,000.

Several other hedge funds and other institutional investors have also made changes to their positions in AVTR. Diversify Advisory Services LLC bought a new stake in shares of Avantor in the 2nd quarter worth about $394,000. Meeder Advisory Services Inc. bought a new position in Avantor during the 2nd quarter valued at about $247,000. Citizens Financial Group Inc. RI bought a new position in Avantor during the 2nd quarter valued at about $229,000. BlackRock Inc. purchased a new stake in Avantor in the 2nd quarter worth about $695,784,000. Finally, Deutsche Bank AG purchased a new stake in Avantor in the 2nd quarter worth about $1,890,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

Avantor stock opened at $13.97 on Thursday. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18. The stock has a market cap of $9.45 billion, a price-to-earnings ratio of -16.63, a price-to-earnings-growth ratio of 10.04 and a beta of 0.89. The firm has a 50-day moving average of $11.44 and a two-hundred day moving average of $9.59. Avantor, Inc. has a 1 year low of $7.26 and a 1 year high of $15.93.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.02. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the company posted $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, research analysts forecast that Avantor, Inc. will post 0.81 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AVTR shares. UBS Group set a $8.00 target price on Avantor in a research report on Wednesday, June 24th. Royal Bank Of Canada raised their price target on Avantor from $9.00 to $14.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $13.00 price objective on shares of Avantor in a report on Thursday, July 30th. Citigroup upped their price objective on Avantor from $9.00 to $11.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Finally, Wall Street Zen upgraded Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Two analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $12.00.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.